News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Events (World)
Cardio3 BioSciences Will Be Present At ODDO Midcap Forum 12/17/2014
Paris, France Will Host Biotechnology Industry Organization (BIO)-Europe Spring 2015 International Life Science Partnering Conference 12/16/2014
Biotech-Cluster BioRN Cluster Management GmbH Leads Innolife Consortium To Success In The Competition Healthy Living And Active Ageing Of The European Institute For Innovation And Technology (EIT) 12/12/2014
Camargo Pharmaceutical Services Release: Israel Seminar Highlights Best Strategies For Developing New Products In Growing Market 12/11/2014
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting 12/11/2014
Merck Announces Positive Data Investigating The Use Of Pembrolizumab In Patients With Advanced Triple-Negative Breast Cancer At 2014 San Antonio Breast Cancer Symposium 12/10/2014
MediWound (MDWD) To Present At Oppenheimer 25th Annual Healthcare Conference 12/9/2014
NeuroDerm Ltd. (NDRM) CEO To Present At Oppenheimer Healthcare Conference On December 10, 2014 12/8/2014
Additional Clinical Data From The Phase 2 Study With Ablynx (ABLYF)'s Anti-vWF Nanobody, Caplacizumab, Presented At The American Society of Hematology Annual Meeting 12/8/2014
Foamix Pharmaceuticals, Ltd. (FOMX) To Present Corporate Overview At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014
UCB Reinforces Its Leadership In Epilepsy At The 2014 Annual Meeting Of The American Epilepsy Society 12/5/2014
Progenics Pharmaceuticals, Inc. (PGNX) Announces Presentation At Radiological Society of North America (RSNA) Annual Meeting 12/5/2014
Bio Blast Pharma To Present Corporate Overview At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Nordic Nanovector To Present Clinical Data From Phase I/II Trial On Betalutin™ At Upcoming American Society of Hematology Meeting 12/3/2014
Jazz Pharmaceuticals (JAZZ) To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At American Society of Hematology Annual Meeting 12/3/2014
Rhizen Pharmaceuticals S.A. To Present Phase 1 Clinical And Additional Preclinical Data Of RP6530 (Dual PI3K Delta/Gamma Inhibitor) In Hematological Malignancies 12/3/2014
Compugen Ltd. (CGEN) To Present At Oppenheimer 25th Annual Healthcare Conference 12/3/2014
Celsus Therapeutics (CLTX) Announces Upcoming Presentation At Oppenheimer 25th Annual Healthcare Conference 12/2/2014
RedHill Biopharma Ltd. (RDHL)To Sponsor And Exhibit Its Ongoing Phase 3 Crohn's Program At The Israeli IBD Society Meeting 12/2/2014
InSightec Invites Radiological Society of North America (RSNA) 2014 Attendees To Learn About Its MR-Guided Focused Ultrasound Solution For Treatment Of Uterine Fibroids And Alleviation Of Pain Caused By Bone Metastases 12/2/2014
AB Science (AB.PA): Web Conference On Masitinib In Asthma - Safety And Efficacy Update 12/1/2014
Zecotek Photonics Inc.'s LFS-3 Scintillation Crystal Plates Successfully Tested For Final Qualification For Hadron Collider Experiments At CERN 12/1/2014
European Medicines Agency Management Board Discusses Next Steps After Judgment Of EU Civil Service Tribunal 12/1/2014
Mettler-Toledo (MTD) Release: Live Webinar On Safe And Cost-Effective Capsule Filling 12/1/2014
e-Therapeutics plc Release: Research And Development Presentation To Investors And Analysts 12/1/2014
Interim Analysis Of NovoCure Ltd.'s Phase 3 Trial In Newly Diagnosed Glioblastoma To Be Presented At Japan Society For Neuro-Oncology 2014 12/1/2014
GRACE Opens Forum For Public Debate Of Its 90-Day Feeding Study With MON810 Maize 11/26/2014
Frost & Sullivan Release: Emerging Technology Advances Neuromodulation While Collaboration Creates Boundless Industry Opportunity 11/26/2014
Novavax, Inc. (NVAX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/26/2014
GW Pharmaceuticals To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/26/2014
Jazz Pharmaceuticals (JAZZ) Announces Participation in Two Investor Conferences 11/25/2014
Sophiris Bio Inc. (SPHS) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/25/2014
VBL Therapeutics (VBLX) To Present Company Overview At Upcoming Conferences 11/25/2014
Alcobra (ADHD) To Present At Investor Conferences In December 11/24/2014
Amarantus To Present At The LD Micro Main Event VII Investor Conference On December 2, 2014 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014
Cellectis (ALCLS) Announces Upcoming Presentations At The 56th Annual Meeting Of American Society of Hematology 11/24/2014
VolitionRX To Present Positive Data From Pilot Lung Cancer Study At Biowin Day 2014 11/24/2014
Lucideon (Formerly Known As CERAM) To Hold Free Breakfast Forum – ‘Materials In Extreme Environments’ – 12 December 2014 11/21/2014
SYGNIS AG To Present At Upcoming Investor Conferences 11/21/2014
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014
uniQure To Host Investor Day In New York City 11/21/2014
Immunomedics, Inc. (IMMU) Presents Clinical Data On Novel Antibody-Drug Conjugates For Solid Cancer Therapy 11/21/2014
IntelGenx Corp. To Present At Singular Research's Best Of The Uncovered 2014 NYC Fall Conference 11/20/2014
Clinical Data Of MediGene AG (MDGEF.PK)'s Dendritic Cell Vaccines To Be Presented At American Society of Hematology Conference 11/20/2014
3-V Biosciences Announces Presentation Of First Human Clinical Data For Lead Oral FASN Inhibitor Candidate At European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research 2014 11/19/2014
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014
Tokai Pharmaceuticals (TKAI) Presents Updated Interim Galeterone ARMOR2 Data Showing Activity In Patients With Castration-Resistant Prostate Cancer (CRPC) Including Those Showing A Variant Form Of Prostate Cancer Resistant To Hormone Therapy 11/19/2014
Helsinn CEO Riccardo Braglia To Present At The Jefferies and Co. 2014 Healthcare Conference 11/18/2014
TAP Biosystems Release: New ambr® 15 Webinar On Overcoming Bottlenecks In Cell Line Development Features Data Showing How This Technology Can Improve Biologics Manufacturing 11/18/2014
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The Stifel Nicolaus 2014 Healthcare Conference 11/18/2014
Debiopharm Group Presents Advances Of Two Key Oncology Clinical Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium In Barcelona 11/18/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/17/2014
Bionomics Limited (BNO.AX) To Present BNC210 At Society For Neuroscience Meeting 11/17/2014
Galapagos NV (GLPG.BR) Presents Clean Drug-Drug Interaction Profile With GLPG0634 (Filgotinib) At ACR 2014 11/17/2014
GW Pharmaceuticals To Present At The Jefferies and Co. 2014 Global Healthcare Conference 11/17/2014
Ablynx (ABLYF) To Present At The Jefferies and Co. 2014 Global Healthcare Conference In London 11/17/2014
Aptose Biosciences To Present At The Stifel 2014 Healthcare Conference 11/17/2014
Epic Sciences To Present Data On A Combination CTC And cfDNA Assay For Molecular Targets Of Non-Small Cell Lung Cancer Therapies At The 26th EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/17/2014
Ablynx (ABLYF) To Present Data On Its Anti-Il-6r Nanobody, Developed In Partnership With AbbVie (ABBV), At The American College of Rheumatology Annual Meeting 11/14/2014
Forward Pharma (FWP) CFO To Present At Two Upcoming Conferences 11/14/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
UCB, Inc. (UCBJF.PK) Shows Strong Scientific Presence At Leading Rheumatology Meeting 11/14/2014
MDxHealth, Inc. (MXDHF) To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum 11/12/2014
Compugen Ltd. (CGEN) To Present At Jefferies and Co. 2014 Global Healthcare Conference In London 11/12/2014
Alliance Life Sciences To Present Global Survey Results At World Orphan Drug Conference 11/10/2014
Sophiris Bio Inc. (SPHS) To Present At The Stifel 2014 Healthcare Conference 11/10/2014
uniQure To Present At Jefferies and Co. Global Healthcare Conference - London 11/10/2014
Pluristem Therapeutics (PSTI) CEO Zami Aberman To Present At Two Regenerative Medicine Conferences In London On November 12 And 13, 2014 11/10/2014
Initial Clinical Data On MediGene AG (MDGEF.PK)'s DC Vaccines To Be Presented At The SITC Conference 11/7/2014
TxCell To Present At EU Advanced Therapies Investor Day November 13, In London, UK 11/7/2014
ProSensa Holding N.V. (RNA) To Present At Upcoming Investor Conferences 11/7/2014
ERYtech Pharma To Report Positive Initial Results On The Use Of GRASPA® In ALL Patients Allergic To E. Coli And Erwinia Derived Asparaginases At American Society of Hematology 11/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Participation In Two Investor Conferences 11/7/2014
MediWound (MDWD) To Present At Two Upcoming Investor Conferences 11/6/2014
DelMar Pharmaceuticals Invited To Present New Data On VAL-083 In The Treatment Of Glioblastoma Multiforme At The Society For NeuroOncology Annual Meeting 11/6/2014
Ablynx (ABLYF) To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, Alx-0171, At 9th International Respiratory Syncytial Virus Symposium 11/6/2014
Oxford Gene Technology Ltd. Release: Pieces Of The Puzzle—A Multi-Method Approach To Tumour Profiling 11/5/2014
Evidera To Give 55 Presentations At ISPOR European Congress, The Most Of Any Attending Company 11/5/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The Credit Suisse 2014 Healthcare Conference 11/5/2014
Galmed Pharmaceuticals To Host Key Opinion Leader Meeting And Webcast On November 7, 2014 In New York City 11/5/2014
VolitionRX To Present At The Seethruequity Conference 11/5/2014
iCo Therapeutics Inc. Announces Oral Amphotericin Presentations At American Association of Pharmaceutical Scientists 11/4/2014
Alcobra (ADHD) To Present At Investor Conferences In November 11/3/2014
GB Sciences Hosts First Medical Cannabis Conference In San Juan, Puerto Rico 11/3/2014
Data From Clinical Study Of Pharmalink AB's Nefecon® To Be Presented At American Society Of Nephrology's Kidney Week 2014 11/3/2014
AB Science (AB.PA): Web Conference On Masitinib In Mastocytosis 11/3/2014
Oramed Pharmaceuticals Inc. (ORMP) To Report Key Top Line Results From U.S. Phase 2a Trial With Oral Insulin In Type 1 Diabetes 11/3/2014
CSL Behring Release: Evidence Presented At The 16th Biennial Meeting Of The European Society For Immunodeficiencies (ESID) Supports Individualized Dosing With Hizentra® 10/31/2014
Molecular Profiles To Launch US Strategic Alliance At AAPS 10/30/2014
Navidea Biopharmaceuticals (NAVB) Announces Scientific Presentations Of Results From Lymphoseek® Studies At The European Association Of Nuclear Medicine And European Society Of Surgical Oncology Meetings 10/30/2014
Can-Fite BioPharma (CFBI) To Participate In Biotechnology Industry Organization (BIO)-Europe International Partnering Conference 10/30/2014
NeuroVive Pharmaceutical AB: Annual General Meeting 2015 And Information About Members Appointed To The Nomination Committee 10/29/2014
PSI Attending 13th Annual Partnerships in Clinical Trials Congress 10/28/2014
ChinaBio® Partnering Forum 2015 To Be Held In Shanghai, China April 22–23, 2015 10/27/2014
Generex Biotechnology Corporation (GNBT) Announces Presentations Correlating Immunological Response With Reduced Recurrence In Phase 2 Study Of AE37 Breast Cancer Vaccine In Patients At The American College of Surgeons 10/27/2014
Head of Innovation For Bayer And The National Director For Patient And Information Of NHS England To Keynote Health 2.0 Europe 2014 10/24/2014
Generex Biotechnology Corporation (GNBT) / Antigen Express, Inc. (GNBT) To Participate In 2014 Biotechnology Industry Organization (BIO)-Europe® Annual International Partnering Conference 10/23/2014
Data Presented At The International Society Of Paediatric Oncology (SIOP) Congress Show Palonosetron Is A Valuable Option For Treating Pediatric Patients Receiving Moderately To Highly Emetogenic Chemotherapy 10/23/2014
Dr. Keith Dunleavy To Speak At IT 2020 Summit In Beijing, China 10/23/2014
ASBM European Survey Presented To Italian Ministry Of Health 10/23/2014
NeuroDerm Ltd. Announces Presentation Of ND0612L Top-Line Phase 2 Results And ND0612H Preliminary Interim Phase 2a Results At The 2014 Parkinson's Disease Therapeutics Conference 10/23/2014
RedHill Biopharma Ltd. (RDHL) To Present At The 20th Annual BIO-Europe International Partnering Conference 10/22/2014
tesa Labtec GmbH Attends 2014 AAPS Annual Meeting And Exposition 10/21/2014
PHT Corporation Hosts New Educational Webinar, “Benefits And ROI Of Ecoa Data Collection In Clinical Trials” 10/21/2014
Phase 2 Data In Crohn’s Disease For Celgene (CELG)’s Oral Antisense Therapy GED-0301 To Be Presented At UEG Week 2014 10/20/2014
Mologen AG (MOLGF.PK): Successful Investigator Meetings For IMPALA Colorectal Cancer Trial 10/20/2014
QIAGEN N.V. (QGEN) Demonstrates Expanded Bioinformatics Workflows At American Society of Human Genetics; Strong Market Adoption As Researchers Analyze Genomic Data On More Than A Quarter-Million Samples In Secure Private Cloud 10/20/2014
DrugDev And AstraZeneca PLC (AZN) To Host Educational Case Study Webinar, “S.O.S. – Best Practices For Finding, Engaging And Activating Investigators On A Rescue Study,” October 21, 2014 10/16/2014
MACROGEN Introduces Latest Service Portfolio And Presents Research Outcome At 2014 ASHG Annual Meeting 10/16/2014
Biotechnology Industry Organization (BIO)-Europe® 2014 Program Is Abundant Showcase Of Life Science Pharma Executives And Thought Leaders 10/16/2014
BIO-Europe® 2014 Program Is Abundant Showcase Of Life Science Pharma Executives And Thought Leaders 10/16/2014
BioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan 2014 10/16/2014
Macrocure (MCUR) To Present At Upcoming Nomura, Credit Suisse And Jefferies and Co. Health Care Conferences In November 10/16/2014
ASBM Presents At WHO Meeting in Geneva 10/16/2014
ThromboGenics NV (TBGNF)'s' Commitment To The U.S. Retina Community Highlighted At American Association Of Ophthalmology 2014 Meeting 10/15/2014
New Irish Tax Rules Won’t Faze Biotech: Analyst 10/14/2014
Novartis AG (NVS)'s Secukinumab Has Consistent Activity In Psoriasis 10/14/2014
Toronto Global Forum To Address: Leveraging Innovation And Technology For Tomorrow's Growth 10/14/2014
OGT Launches Medical Research Exome Array At ASHG 10/14/2014
AAAS Release: The 1st Meeting Of The Series Bridging Biomedical Worlds: “Turning Obstacles Into Opportunities For Stem Cell Therapy” 10/13/2014
AbbVie (ABBV) Announces Late-Breaking Results From Phase 3 Trial Of HUMIRA® (Adalimumab) In Hidradenitis Suppurativa (HS) Patients At The European Academy Of Dermatology And Venereology Congress 10/13/2014
Meeting Highlights From The Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 October 2014 10/10/2014
Fraunhofer Release: Experts Discussed New Developments In The Field Of Stem Cell Research And Cell Therapy 10/10/2014
Janssen Research & Development Demonstrates Continued Commitment To Combating Hepatitis C In European Patients With Data Presented At Viral Hepatitis Congress 10/10/2014
Ironwood Pharmaceuticals (IRWD) And Actavis (ACT) To Present Linaclotide Data At The American College of Gastroenterology 2014 Annual Scientific Meeting 10/9/2014
CARMAT Is Participating In The 28th EACTS Annual Meeting In Milan (Italy) 10/9/2014
InSightec To Share Key Insights And Progress At The 4th Focused Ultrasound International Symposium 10/9/2014
VolitionRX Presents Further Colorectal Cancer Data At 9th International Conference Of Anticancer Research 10/9/2014
Galapagos NV (GLPG.BR) Presents Novel Cystic Fibrosis Combination Therapy At NACFC 10/9/2014
Precious Cells Group Release: National Stem Cell Awareness Day: Over A Quarter Of Parents Are Still Not Being Informed About The Life-Saving Potential Of Storing Or Donating Umbilical Cord Blood Stem Cells 10/8/2014
BIO-Europe® 2014 Partnering Meetings Expected To Surpass All Previous Events 10/8/2014
Mabion At The Trade Fair CPhl In Paris 10/8/2014
Biotechnology Industry Organization (BIO) Deutschland Release: 8th European Business Development Brings Pharma And Biotech Together 10/8/2014
Cell Source To Present At The Firerock Conference And The Life Sciences Summit In New York City On October 28th And 29th, 2014 10/8/2014
REPLICor Inc. To Present Updated Clinical Trial Data With Combination Treatment Using Its HBsAg-Release Inhibitors In Patients With Chronic Hepatitis B Infection At The 10th Annual Meeting Of The Oligonucleotide Therapeutics Society (OTS) 10/8/2014
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014
Can-Fite BioPharma (CFBI) CEO Dr. Pnina Fishman To Co-Chair And Present At The 19th World Congress On Advances In Oncology's Cancer Therapeutics Session 10/7/2014
MediWound (MDWD)'s Nexobrid To Be Featured At International Society For Burn Injuries 2014 10/7/2014
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
DelMar Pharmaceuticals Announces Presentations At Upcoming Scientific Meetings 10/6/2014
Vitrolife (VITR.ST): Invitation To Capital Markets Day On November 6 10/6/2014
Mundipharma AG Presents Four Posters On “Pain Management In Asia” At The International Association For The Study Of Pain’s 15th World Congress On Pain In Buenos Aires, Argentina 10/6/2014
TxCell To Present Latest Developments Of Its Personalized Cell-Based Immunotherapy Platform, Astria, At The 13th TxCell Investor Forum 2014 10/2/2014
SIRO Clinpharm (India) Showcases Biometrics Capabilities At The SCDM 2014 Annual Conference In Las Vegas 10/2/2014
Molecular Profiles To Launch New Development Platform At CPhI 10/2/2014
Nexstim Supports 6th International Symposium On Navigated Brain Stimulation In Neurosurgery 10/2/2014
UBM Release: CPhI Exhibitors Announce Their Latest Products Set to Drive Tomorrow's Pharmaceutical Industry 10/2/2014
BioJapan 2014 World Business Forum Exhibitor Profiles 10/1/2014
Pressure BioSciences, Inc. (BBII) Invited To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland 10/1/2014
Mucosis B.V. Presents Infectious Diseases Vaccines Pipeline Update At Sachs Associates - Bloomberg L.P. 14th Annual Biotech In Europe Forum 9/30/2014
Sophiris Bio Inc. (SPHS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Cortendo AB To Present At The Epic Biotech Conference In London On October 2, 2014 9/30/2014
GenSpera To Present Lead Drug Candidate Mipsagargin At 2nd Global Life Sciences Conference In Warsaw, Poland 9/30/2014
Novogen Limited (NVGN) Release: Graham Kelly Phd, CEO & Chairman Attended The Rodman & Renshaw 16th Annual Global Investment Conference 9/29/2014
Cortendo AB To Present At The 14th Annual BIOTECH In Europe Forum In Basel September 30, 2014 9/29/2014
MEDTEC Ireland Returns to Galway This October 9/29/2014
Presented By The Japanese Cancer Association And Debiopharm Group™, The ‘JCA-Mauvernay Award 2014’ Goes To Doctors Hara And Shibata 9/26/2014
Simbec-Orion To Attend ESMO 2014 Congress 9/25/2014
Helsinn Announces That Pivotal Phase 3 Trial Data For Anamorelin In ROMANA 1 And 2 Studies In Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia Will Be Presented At The 38th European Society For Medical Oncology (ESMO) Congress In 2014 9/25/2014
Latest Discoveries In Oncology to be Presented At ESMO 2014 9/24/2014
Neovacs SA Will Attend Société Générale's "Healthcare & Biotechnology Conference" For The Second Time On 24 September 2014 9/23/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event 9/22/2014
TxCell To Participate At Société Générale Healthcare & Biotechnology Conference, Paris 9/22/2014
RedHill Biopharma Ltd. (RDHL) To Present At The 14th Annual Biotech In Europe Forum For Global Partnering & Investment 9/16/2014
Heptares To Present On Structure-Based Drug Design Using G Protein-Coupled Receptors At Inaugural Chemistry & Engineering News Virtual Symposium 9/16/2014
TiGenix To Participate Or Present At Key Conferences In The Second Half Of 2014 9/15/2014
RedHill Biopharma Ltd. (RDHL) To Present At The 7th Annual Biopharm America International Partnering Conference 9/15/2014
Skyepharma PLC (SKYEF) To Present At Innovation In Respiratory Diseases Event 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Amarantus BioSciences, Inc. To Present Orphan Ocular Data At Targeting Ocular Disorders Conference 2014 9/11/2014
Pluristem Therapeutics (PSTI) To Deliver Scientific Presentations At 3rd International Placenta Stem Cell Society Meeting 9/10/2014
SELLAS Life Sciences Group To Present At The Annual AEGIS Healthcare & Technology Conference 9/9/2014
Genticel To Participate In The Rodman & Renshaw Investor Conference In New York – From September 8 To 10 9/8/2014
Biotechnology Industry Organization (BIO) Latin America Conference Connects International Industry Leaders 9/8/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
Nabriva Therapeutics Presented Data On Lead Pleuromutilin Antibiotic Lefamulin (BC-3781) At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy In Washington DC 9/8/2014
OSE Pharma To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
DelMar Pharmaceuticals To Present At The SeeThruEquity Fall Microcap Investor Conference 9/8/2014
Alcobra (ADHD) To Present At The Aegis Healthcare & Technology Conference 9/5/2014
RedHill Biopharma Ltd. (RDHL) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/5/2014
Teva Pharmaceutical Industries Limited (TEVA) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014
Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida To Present Poster On Epro For Multiple Myeloma At ESMO 2014 Congress 9/4/2014
Amarantus BioSciences, Inc. To Present At Sachs Associates 14th Annual Biotech In Europe Forum For Global Partnering And Investment 9/4/2014
Protalix Biotherapeutics, Inc. (PLX) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
Two Presentations At International Conferences Of Preclinical Data On NOXXON Pharma AG’s anti-C5a Spiegelmer®, A Potential Drug In Pneumococcal Pneumonia-Induced Sepsis 9/4/2014
Pluristem Therapeutics (PSTI) To Present At Financial Conferences In New York City On September 10th And 17th, 2014 9/4/2014
Cell Source To Present At Rodman & Renshaw Global Investment Conference In New York City On September 10, 2014 9/3/2014
Mallinckrodt Pharmaceuticals (MNK) To Hold Investor Briefing October 14, 2014, In New York 9/3/2014
Cipher Pharmaceuticals (DND.TO) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/3/2014
Nosopharm Shares Scientific Data On Odilorhabdins, A Novel Antibacterial Class With The Potential To Combat Antibiotic Resistance 9/3/2014
Imperial College London To Present First Public HBV Data From CN Biosciences (CNBI) In Vitro Liver Model 9/2/2014
Protalix Biotherapeutics, Inc. (PLX) Announces Conference Call To Discuss ELELYSO Pediatric Approval And Provide Updates On Additional Programs 8/29/2014
DBV Technologies To Attend The Goldman, Sachs & Co. European Biotech Symposium 8/26/2014
Elekta: Welcome To Elekta’s Capital Markets Day At ASTRO 8/22/2014
PHT Corporation Presents Educational Webinar On Collecting Electronic Outcome Assessment (ECOA) Data In Oncology Programs 8/21/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Prothena Corporation plc Release: Dr. Dale Schenk To Discuss Parkinson's Disease At 2014 Rejuvenation Biotechnology Conference 8/19/2014
CPhI Korea Opens As Forecasts Predict Value Of South Korean Pharma Market To Reach $24.3 Billion By 2020 8/18/2014



//-->